Pfizer Limited (PFIZER) Share Price
NSE · Healthcare · Drug Manufacturers - General · ISIN INE182A01018
Key metrics
- Market Cap
- ₹21,345 Cr
- P/E Ratio
- 29
- EPS
- 160.67
- Book Value
- 918.71
- P/B Ratio
- 5.1
- ROE
- 17.19%
- ROCE
- 19.82%
- Debt / Equity
- 0.02
- Net Margin
- 28.68%
- Revenue Growth
- 10.45%
- Profit Growth
- -5.88%
- Dividend Yield
- 1.6%
- 52W High
- ₹5,578.50
- 52W Low
- ₹4,360.10
- Market Cap Band
- large cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Pfizer Limited
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterology, pain management, and nutrition, addressing. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 1,244
- Promoter Holding
- 66.95%
The full Pfizer Limited analysis
Create a free account to open the complete PFIZER deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.